{"entity":{"type":"insider","cik":"0001376171","url":"/insider/0001376171","json_url":"/insider/0001376171.json","name":"AISLING CAPITAL PARTNERS LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2012-02-09","last":"2015-04-27","span_basis":"filed_date"},"name_variants":[{"name":"AISLING CAPITAL PARTNERS LLC","source":"filing","n_filings":4,"first_seen":"2012-02-09","last_seen":"2015-04-27"}],"transactions":[{"id":8897943,"accession":"0000950142-15-000894","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950142-15-000894","line_url":"/filing/0000950142-15-000894#line-3","is_derivative":false,"issuer_cik":"0001172252","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001172252","owner_cik":null,"owner_name":"AISLING CAPITAL PARTNERS LLC; AISLING CAPITAL PARTNERS, LP; ELMS STEVE; Aisling Capital II LP; SCHIFF ANDREW N; Purcell Dennis J","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61726.0,"shares_display":"61,726","price_per_share":106.1,"price_display":"106.10","price_state":"stated","total_value":6549128.6,"total_display":"6,549,128.60","shares_owned_after":1837125.0,"shares_owned_after_display":"1,837,125","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-04-24","filed_date":"2015-04-27","scope":"insider"},{"id":8897941,"accession":"0000950142-15-000894","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950142-15-000894","line_url":"/filing/0000950142-15-000894#line-2","is_derivative":false,"issuer_cik":"0001172252","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001172252","owner_cik":null,"owner_name":"AISLING CAPITAL PARTNERS LLC; AISLING CAPITAL PARTNERS, LP; ELMS STEVE; Aisling Capital II LP; SCHIFF ANDREW N; Purcell Dennis J","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5743.0,"shares_display":"5,743","price_per_share":108.0,"price_display":"108.00","price_state":"stated","total_value":620244.0,"total_display":"620,244.00","shares_owned_after":1898851.0,"shares_owned_after_display":"1,898,851","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-04-24","filed_date":"2015-04-27","scope":"insider"},{"id":8897938,"accession":"0000950142-15-000894","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950142-15-000894","line_url":"/filing/0000950142-15-000894#line-1","is_derivative":false,"issuer_cik":"0001172252","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001172252","owner_cik":null,"owner_name":"AISLING CAPITAL PARTNERS LLC; AISLING CAPITAL PARTNERS, LP; ELMS STEVE; Aisling Capital II LP; SCHIFF ANDREW N; Purcell Dennis J","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":109.1,"price_display":"109.10","price_state":"stated","total_value":16365000.0,"total_display":"16,365,000.00","shares_owned_after":1904594.0,"shares_owned_after_display":"1,904,594","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-04-23","filed_date":"2015-04-27","scope":"insider"},{"id":4769147,"accession":"0000950142-13-002123","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950142-13-002123","line_url":"/filing/0000950142-13-002123#line-1","is_derivative":false,"issuer_cik":"0001172252","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001172252","owner_cik":null,"owner_name":"AISLING CAPITAL PARTNERS, LP; ELMS STEVE; Purcell Dennis J; AISLING CAPITAL PARTNERS LLC; Aisling Capital II LP; SCHIFF ANDREW N","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":411765.0,"shares_display":"411,765","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":3500002.5,"total_display":"3,500,002.50","shares_owned_after":3620143.0,"shares_owned_after_display":"3,620,143","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-10-22","filed_date":"2013-10-23","scope":"insider"},{"id":4228269,"accession":"0001179110-13-011142","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-011142","line_url":"/filing/0001179110-13-011142#line-2","is_derivative":false,"issuer_cik":"0001172252","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001172252","owner_cik":null,"owner_name":"AISLING CAPITAL PARTNERS, LP; Purcell Dennis J; ELMS STEVE; AISLING CAPITAL PARTNERS LLC; SCHIFF ANDREW N; Aisling Capital II LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":238119.0,"shares_display":"238,119","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":3333666.0,"total_display":"3,333,666.00","shares_owned_after":2054594.0,"shares_owned_after_display":"2,054,594","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-01","filed_date":"2013-07-01","scope":"insider"},{"id":2720481,"accession":"0000950142-12-000248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950142-12-000248","line_url":"/filing/0000950142-12-000248#line-1","is_derivative":false,"issuer_cik":"0001172252","issuer_name":"CEMPRA, INC.","issuer_ticker":"CEMP","issuer_name_source":null,"issuer_url":"/issuer/0001172252","owner_cik":null,"owner_name":"Purcell Dennis J; AISLING CAPITAL PARTNERS, LP; Aisling Capital II LP; SCHIFF ANDREW N; AISLING CAPITAL PARTNERS LLC; ELMS STEVE","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1213663.0,"shares_display":"1,213,663","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":7281978.0,"total_display":"7,281,978.00","shares_owned_after":3293060.0,"shares_owned_after_display":"3,293,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-07","filed_date":"2012-02-09","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434868","name":"Esperion Therapeutics, Inc.","url":"/issuer/0001434868","role":"Ten percent owner","n_filings":2,"first_seen":"2013-07-01","last_seen":"2015-04-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001368514","name":"ADMA BIOLOGICS, INC.","url":"/issuer/0001368514","role":"Ten percent owner","n_filings":1,"first_seen":"2013-10-23","last_seen":"2013-10-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001461993","name":"CEMPRA, INC.","url":"/issuer/0001461993","role":"Ten percent owner","n_filings":1,"first_seen":"2012-02-09","last_seen":"2012-02-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001376171","retrieved_at":"2026-08-22T04:37:42+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}